Cuifen Zhao

434 total citations
18 papers, 217 citations indexed

About

Cuifen Zhao is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Cuifen Zhao has authored 18 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Cuifen Zhao's work include Cardiovascular Syncope and Autonomic Disorders (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). Cuifen Zhao is often cited by papers focused on Cardiovascular Syncope and Autonomic Disorders (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). Cuifen Zhao collaborates with scholars based in China and United States. Cuifen Zhao's co-authors include Qingyu Kong, Hong Qiu, Javier E. López, Ning Li, Nipavan Chiamvimonvat, Jun‐Yan Liu, Padmini Sirish, Kin Sing Stephen Lee, Sung Hee Hwang and Bruce D. Hammock and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Biomedicine & Pharmacotherapy.

In The Last Decade

Cuifen Zhao

17 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuifen Zhao China 7 102 68 56 39 37 18 217
Dating Sun China 10 98 1.0× 28 0.4× 46 0.8× 33 0.8× 35 0.9× 12 218
Ajeeth K. Pingili United States 13 107 1.0× 37 0.5× 81 1.4× 97 2.5× 51 1.4× 18 348
Akina Omori Japan 8 201 2.0× 22 0.3× 75 1.3× 51 1.3× 63 1.7× 8 328
Maija Ruuth Finland 10 92 0.9× 24 0.4× 38 0.7× 82 2.1× 118 3.2× 18 278
Christoph Schmöcker Germany 7 45 0.4× 73 1.1× 11 0.2× 33 0.8× 65 1.8× 15 277
Lingdan Chen China 9 109 1.1× 36 0.5× 12 0.2× 26 0.7× 44 1.2× 15 255
Thorben Ravekes Germany 6 63 0.6× 48 0.7× 56 1.0× 16 0.4× 18 0.5× 6 216
Liang‐Jie Tang China 11 86 0.8× 38 0.6× 21 0.4× 64 1.6× 34 0.9× 25 337
Anne O’Connor United Kingdom 4 103 1.0× 34 0.5× 147 2.6× 17 0.4× 64 1.7× 4 280

Countries citing papers authored by Cuifen Zhao

Since Specialization
Citations

This map shows the geographic impact of Cuifen Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuifen Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuifen Zhao more than expected).

Fields of papers citing papers by Cuifen Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuifen Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuifen Zhao. The network helps show where Cuifen Zhao may publish in the future.

Co-authorship network of co-authors of Cuifen Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Cuifen Zhao. A scholar is included among the top collaborators of Cuifen Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuifen Zhao. Cuifen Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Qing, et al.. (2025). Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies. Future Microbiology. 20(4). 357–369. 2 indexed citations
2.
Peng, Lu, et al.. (2023). Predictive analysis of catecholamines and electrolytes for recurrence of orthostatic intolerance in children. Frontiers in Pediatrics. 11. 1 indexed citations
3.
Xu, Xue, et al.. (2023). Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. European Journal of Pediatrics. 182(10). 4399–4406. 1 indexed citations
4.
Kong, Qingyu, et al.. (2023). Analysis of the disease burden of cardiomyopathy in children aged 0–14 years in China from 1990 to 2019. Frontiers in Public Health. 11. 1198924–1198924.
5.
Wang, Minmin, et al.. (2023). Predictive value of EGSYS score in the differential diagnosis of cardiac syncope and neurally mediated syncope in children. Frontiers in Cardiovascular Medicine. 10. 1091778–1091778. 1 indexed citations
6.
Kong, Qingyu, et al.. (2023). Global, Regional, and National Burden of Myocarditis in 204 Countries and Territories From 1990 to 2019: Updated Systematic Analysis. JMIR Public Health and Surveillance. 10. e46635–e46635. 5 indexed citations
7.
Kang, Zhensheng, et al.. (2022). Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn. Journal of Cardiovascular Pharmacology. 81(3). 232–239. 6 indexed citations
8.
Kong, Qingyu, et al.. (2021). circ‑Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS. International Journal of Molecular Medicine. 48(5). 19 indexed citations
9.
Kang, Zhensheng, et al.. (2020). Recombinant human insulin-like growth factor binding protein 3 attenuates lipopolysaccharide-induced acute lung injury in mice.. PubMed. 13(7). 1924–1931. 3 indexed citations
10.
Li, Wei, et al.. (2019). MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis. Cardiology Journal. 27(3). 285–294. 20 indexed citations
11.
Yang, Xiaofei, et al.. (2019). New pathogenic variant ofBMPR2in pulmonary arterial hypertension. Cardiology in the Young. 29(4). 462–466. 1 indexed citations
12.
Kong, Qingyu, et al.. (2019). Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope. Irish Journal of Medical Science (1971 -). 188(4). 1279–1287. 11 indexed citations
13.
Dai, Na, et al.. (2019). Vascular repair and anti‑inflammatory effects of soluble epoxide hydrolase inhibitor. Experimental and Therapeutic Medicine. 17(5). 3580–3588. 13 indexed citations
14.
Yang, Xiaofei, et al.. (2018). Association between the promoter methylation of the TBX20 gene and tetralogy of fallot. Scandinavian Cardiovascular Journal. 52(5). 287–291. 10 indexed citations
15.
Kong, Qingyu, et al.. (2017). Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus. Biomedicine & Pharmacotherapy. 94. 619–626. 36 indexed citations
16.
Li, Wei, Mengmeng Liu, Cuifen Zhao, et al.. (2015). Urotensin II contributes to collagen synthesis and up-regulates Egr-1 expression in cultured pulmonary arterial smooth muscle cells through the ERK1/2 pathway. Biochemical and Biophysical Research Communications. 467(4). 1076–1082. 6 indexed citations
17.
Sirish, Padmini, Ning Li, Jun‐Yan Liu, et al.. (2013). Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis. Proceedings of the National Academy of Sciences. 110(14). 5618–5623. 77 indexed citations
18.
Li, Wei, et al.. (2011). Inhibitor of DNA-binding-1/inhibitor of differentiation-1 (ID-1) is implicated in various aspects of gastric cancer cell biology. Molecular Biology Reports. 39(3). 3009–3015. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026